Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Current Opinion in Clinical Nutrition and Metabolic Care|August 19, 2016
Changes in circulating vitamin D levels with loss of adipose tissueAnne Gangloff, Jean Bergeron, Isabelle Lemieux, et al.
The American Journal of Clinical Nutrition|February 26, 2003
Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultryEdith Beauchesne-Rondeau, Annie Gascon, Jean Bergeron, et al.
Journal of Clinical Lipidology|February 5, 2011
Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein BAllan Sniderman, Andre Tremblay, Jean Bergeron, et al.
Lipids in Health and Disease|May 12, 2004
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligoMartin Noël, Claude Gagné, Jean Bergeron, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|September 5, 2001
Comparison of two techniques for measurement of visceral adipose tissue cross-sectional areas by computed tomographySimone Lemieux, Marie Lesage, Jean Bergeron, et al.
Revue Medicale Suisse|October 3, 2024
[Statin-associated muscle symptoms : performance and quality of life]Paul Peyrel, Pascale Mauriège, Jérôme Frenette, et al.
SAGE Open Medical Case Reports|October 24, 2022
A case of eruptive xanthomas associated with pregnancy unmasking a G188E heterozygous mutation of the lipoprotein lipase gene: A case reportCaroline Paquette, Anne-Marie Careau, Jean Bergeron, et al.
Metabolism: Clinical and Experimental|August 11, 2005
Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrationsAndré J Tremblay, Jean Bergeron, Jean-Marc Gagné, et al.
Clinical Science (London, England : 1979)|September 18, 2007
Non-HDL cholesterol and apoB in dyslipidaemiaAllan D Sniderman, Jean-Charles Hogue, Jean Bergeron, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 16, 2005
Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patientsSimon Desmeules, Jean-François Arcand-Bossé, Jean Bergeron, et al.
Pageof 18